Showing results (31-40 of 492) with videos related to

Sort By:
Pageof 50
Journal of Leukocyte Biology|September 4, 2004
G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyteGiuseppe Sconocchia, Hiroshi Fujiwara, Katayoun Rezvani, et al.
Nature Reviews. Cancer|July 25, 2022
Natural killer cells in antitumour adoptive cell immunotherapyTamara J Laskowski, Alexander Biederstädt, Katayoun Rezvani
Blood|April 28, 2007
Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemiaElena E Solomou, Katayoun Rezvani, Stephan Mielke, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 13, 2006
Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantationBipin N Savani, Aldemar Montero, Ramaprasad Srinivasan, et al.
Blood|September 19, 2007
Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignanciesKatayoun Rezvani, Agnes S M Yong, Stephan Mielke, et al.
Frontiers in Medicine|January 19, 2016
Cord Blood as a Source of Natural Killer CellsRohtesh S Mehta, Elizabeth J Shpall, Katayoun Rezvani
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 3, 2017
Engineering Natural Killer Cells for Cancer ImmunotherapyKatayoun Rezvani, Rayne Rouce, Enli Liu, et al.
Blood|July 28, 2005
The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactionsGiuseppe Sconocchia, Michelle Lau, Maurizio Provenzano, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
New developments in allotransplant immunologyA John Barrett, Katayoun Rezvani, Scott Solomon, et al.
Blood|April 22, 2006
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCTKatayoun Rezvani, Stephan Mielke, Mojgan Ahmadzadeh, et al.
Pageof 50